Save time and get answers to complex questions with AI chat
What's the advised delay for milk post lipitor?Combivent generic equivalent?Excipients list used in dexamethasone creams?Motegrity ingredients?Alogliptin benzoate cost?
See the DrugPatentWatch profile for Sprycel
Sprycel (dasatinib) isn’t protected by a single global “expiry date.” Patent protection for dasatinib exists in multiple patent families (composition of matter, salt/formulation patents, use-method patents, etc.) plus regulatory data exclusivities. Expiry dates vary by country and by which patent family or exclusivity is still in force. If you want a concrete answer, tell me the country (e.g., United States, Europe, India, etc.). I can look up the current status and summarize: - which patents or exclusivities are still active, - the expected expiry dates for each, - whether generic versions are or will be available in that market. If you’d like to do it yourself, you can check: - US: FDA Orange Book for dasatinib patents and exclusivities, - Europe: European Patent Office / Espacenet and the EMA/market authorization data, - Other countries: national patent databases (and local regulatory orange book equivalents). Would you like me to pull specific expiry info for a particular country?
Other Questions About Sprycel :